# Phase 1 colorectal cancer trials recruiting: 156 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 156 trials in phase 1 for colorectal cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 colorectal cancer trials: 156 rows for $7.80, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/colorectal-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 156
- Recruiting or not yet: 156
- Read on: November 19, 2026

## Trials

The 25 newest of 156, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07903857 | SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors | Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903857) |
| October 22, 2026 | NCT07890246 | A Phase 1 Study of IM-1340 in Participants With Advanced Cancer | Immunome, Inc. | Phase 1 | Not yet recruiting | Colorectal Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Neuroendocrine Neoplasm | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890246) |
| October 22, 2026 | NCT07887971 | A Study of \[225Ac\]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors | Aktis Oncology, Inc. | Phase 1 | Recruiting | NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), ES-SCLC, Small Cell Lung Cancer Extensive Stage, B7H3, Prostate... | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887971) |
| October 16, 2026 | NCT07878988 | This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic... | LTZ Therapeutics, Inc. | Phase 1 | Recruiting | Colorectal Cancer, Advanced/Metastatic Solid Tumor, Solid Tumor (Phase I), EPCAM, Colon Cancer | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878988) |
| October 15, 2026 | NCT07875920 | Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation | Neowise Biotechnology | Phase 1 | Not yet recruiting | Advanced Solid Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Adenocarcinoma, Lung Adenocarcinoma, KRAS... | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875920) |
| October 15, 2026 | NCT07874880 | MTX-531-001 Phase 1 Study in Advanced Solid Tumors | MEKanistic Therapeutics, Inc. | Phase 1 | Not yet recruiting | Solid Tumors (Phase 1), HNSCC, Endometrial Cancer, Her2-negative Metastatic Breast Cancer, Pan-RAS and BRAF Wild-type... | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874880) |
| October 5, 2026 | NCT07859085 | A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable... | Genentech, Inc. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma | 388 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859085) |
| September 25, 2026 | NCT07842965 | CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal... | City of Hope Medical Center | Phase 1 | Not yet recruiting | Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8 | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842965) |
| September 16, 2026 | NCT07822399 | A Study of MGC030 in Participants With Advanced Solid Tumors | MacroGenics | Phase 1 | Recruiting | Urothelial Cancer, GastroEsophageal Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC), Pancreatic Cancer | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822399) |
| September 10, 2026 | NCT07812805 | SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | SK Life Science, Inc. | Phase 1 | Recruiting | Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812805) |
| September 8, 2026 | NCT07807956 | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807956) |
| September 8, 2026 | NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | Sutro Biopharma, Inc. | Phase 1 | Recruiting | Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal Cancer... | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807345) |
| September 4, 2026 | NCT07805369 | A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer | DEM BioPharma, Inc. | Phase 1 | Recruiting | Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805369) |
| July 31, 2026 | NCT07738939 | IKS04 Regimen in Advanced Solid Tumors That Express CA242 | Iksuda Therapeutics Ltd. | Phase 1 | Not yet recruiting | Colorectal Cancer, Gastro Esophageal Junctional Cancer, Gastric Cancer (GC), GEJ Adenocarcinoma, PDAC - Pancreatic... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738939) |
| July 21, 2026 | NCT07715903 | Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump... | National Cancer Institute (NCI) | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Neoplasms, Intrahepatic Cholangiocarcinoma, Adrenocortical Carcinoma, Metastasis, Neoplasm | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715903) |
| June 22, 2026 | NCT07661641 | A Study of \[177Lu\]Lu-A9-0631 and \[225Ac\]Ac-A9-0642 With \[68Ga\]Ga-A9-6217 or \[177Lu\]Lu-A9-0631 Imaging in GRPR+ Solid Tumors | Alpha-9 Oncology USA Inc. | Phase 1 | Recruiting | Breast Cancer, Prostate Cancer, Colorectal Cancer, GRPR-positive Solid Tumors | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661641) |
| June 16, 2026 | NCT07650357 | A Study of CLSP 5282 in HLA-A\*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) | Clasp Therapeutics, Inc. | Phase 1 | Not yet recruiting | Advanced Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Carcinoma, Colorectal Cancer | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650357) |
| June 16, 2026 | NCT07649655 | EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 | Recruiting | Unresectable/Metastatic Colorectal Cancer | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649655) |
| June 12, 2026 | NCT07646106 | THE-0504 in Patients With Solid Tumors | Thena Biotech S.r.l. | Phase 1 | Recruiting | Small Cell Lung Cancer (SCLC), Colorectal Carcinoma (CRC), Gastric Cancer (GC), Triple -Negative Breast Cancer... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646106) |
| June 5, 2026 | NCT07630961 | Phase I Study of JFI447 \[68Ga\]Ga-DFC413 and Comparison to FFG233 \[68Ga\]Ga-NNS309 in Patients With Solid Tumors | Novartis Pharmaceuticals | Phase 1 | Recruiting | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC), HR+/HER2- Ductal Breast Cancer... | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630961) |
| June 3, 2026 | NCT07624214 | Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Phase 1 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid... | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624214) |
| June 3, 2026 | NCT07623369 | A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors | Huahui Health | Phase 1 | Recruiting | Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Head and Neck Squamous Cell... | 299 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623369) |
| May 18, 2026 | NCT07594067 | TCR1188-ABC Cells in KRAS-mutated Cancers | University of Pennsylvania | Phase 1 | Recruiting | Cholangiocarcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594067) |
| May 15, 2026 | NCT07589205 | Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | Phase 1 | Recruiting | Solid Tumor, Colorectal Cancer, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Head and Neck Squamous... | 493 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589205) |
| May 14, 2026 | NCT07587827 | Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or... | Centre Georges Francois Leclerc | Phase 1 | Not yet recruiting | Metastatic Colorectal Cancer (CRC), Locally Advanced Colorectal Cancer, Metastatic Pancreatic Cancer, Locally Advanced... | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587827) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 8 |
| City of Hope Medical Center | 4 |
| Hefei TG ImmunoPharma Co., Ltd. | 3 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 3 |
| [MacroGenics](https://specstream.ai/data/clinical-trials/company/macrogenics) | 3 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 3 |
| West China Hospital | 2 |
| M.D. Anderson Cancer Center | 2 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2 |
| Sutro Biopharma, Inc. | 2 |
| Myeloid Therapeutics | 2 |
| [Revolution Medicines, Inc.](https://specstream.ai/data/clinical-trials/company/revolution-medicines-inc) | 2 |
| [Jiangsu Hansoh Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/jiangsu-hansoh-pharmaceutical-co-ltd) | 2 |
| [Hansoh BioMedical R&D Company](https://specstream.ai/data/clinical-trials/company/hansoh-biomedical-r-and-d-company) | 2 |
| Kumquat Biosciences Inc. | 2 |
| Kivu Bioscience Inc. | 2 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| [Sichuan Baili Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sichuan-baili-pharmaceutical-co-ltd) | 2 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 2 |
| Immunome, Inc. | 2 |
| Radiopharm Theranostics, Ltd | 1 |
| Degron Therapeutics Co. | 1 |
| University of California, Irvine | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 88 |
| China | 43 |
| Australia | 25 |
| Spain | 19 |
| France | 15 |
| Canada | 13 |
| South Korea | 11 |
| Germany | 10 |
| Italy | 10 |
| Japan | 10 |
| United Kingdom | 8 |
| Belgium | 6 |
| Denmark | 5 |
| Netherlands | 5 |
| Israel | 4 |
| Poland | 3 |
| Switzerland | 2 |
| Taiwan | 2 |
| Austria | 1 |
| New Zealand | 1 |
| Georgia | 1 |
| Malaysia | 1 |
| Brazil | 1 |
| Singapore | 1 |
| Egypt | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Private schools in the United States](https://specstream.ai/data/businesses/private-schools/united-states)
- [Publishers in the United States](https://specstream.ai/data/businesses/publishers/united-states)
- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Scale suppliers in the United States](https://specstream.ai/data/businesses/scale-suppliers/united-states)
- [Sign makers in the United States](https://specstream.ai/data/businesses/sign-makers/united-states)
- [Speech training companies in the United States](https://specstream.ai/data/businesses/speech-training-companies/united-states)
